Kockan, B. Et Al. 2018. Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia. ONCOLOGY LETTERS , vol.15 , 2419-2424.

Kockan, B., Toptaş, T., Atagündüz, I., Tuğlular, A. T., Ozer, A., & Akkiprik, M., (2018). Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia. ONCOLOGY LETTERS , vol.15, 2419-2424.

Kockan, Betul Et Al. "Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia," ONCOLOGY LETTERS , vol.15, 2419-2424, 2018

Kockan, Betul Et Al. "Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia." ONCOLOGY LETTERS , vol.15, pp.2419-2424, 2018

Kockan, B. Et Al. (2018) . "Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia." ONCOLOGY LETTERS , vol.15, pp.2419-2424.

@article{article, author={Betul Kockan Et Al. }, title={Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia}, journal={ONCOLOGY LETTERS}, year=2018, pages={2419-2424} }